Skip to main content
. 2015 Apr 13;10(4):e0122376. doi: 10.1371/journal.pone.0122376

Fig 1. The Speckle Tracking methodology.

Fig 1

(A) Healthy control subject. (B) Individual affected by Hypertrophic Cardiomyopathy.